rel-Benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

2304514-60-9rel-Benzyl (3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

● In Stock

Catalogue No.:VE0024621
CAS No.:2304514-60-9
Mol. Formula:C16H20BrNO3
Mol. Weight:354.24 g/mol

Additional information on CAS 2304514-60-9

Parent drug

Upadacitinib

IUPAC Name

rel-Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

Pharmacopoeial Synonyms

N/A

Other Synonyms

Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate, rel-; Benzyl (3R, 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate

Smiles

O=C(N1C[C@H](C(CBr)=O)[C@@H](CC)C1)OCC2=CC=CC=C2

InChI

InChI=1S/C16H20BrNO3/c1-2-13-9-18(10-14(13)15(19)8-17)16(20)21-11-12-6-4-3-5-7-12/h3-7, 13-14H, 2, 8-11H2, 1H3/t13-, 14-/m0/s1

Description

rel-Benzyl (3R | 4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate is a well-characterized reference material that meets stringent regulatory standards set by USP | EMA | JP | and BP. It plays a key role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Upadacitinib.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url